Roche Molecular Systems Investor Relations Manager Salaries in Boulder | Comparably
Roche Molecular Systems, Inc., a molecular diagnostics company, develops and commercializes diagnostic and blood screening tests based on read more
EMPLOYEE
PARTICIPANTS
15
TOTAL
RATINGS
176

Roche Molecular Systems Investor Relations Manager Salaries in Boulder

The average Roche Molecular Systems Investor Relations Manager in Boulder earns an estimated $98,211 annually. Roche Molecular Systems' Investor Relations Manager compensation is $10,907 more than the US average for a Investor Relations Manager.

In Boulder, The Communications Department at Roche Molecular Systems earns $35,150 more on average than the Business Development Department.

Last updated a year ago.

$51k
$64k
$75k
$85k
$114k
$175k
$98,211
Average Compensation
$98,211
avg. base

Investor Relations Manager Salaries at Roche Molecular Systems

* estimated salary

Compensation at Roche Molecular Systems by Department

In Boulder, The Communications Department averages $35,150 more than the Business Development Department, and $431 less than the Enterprise Risk Department

Enterprise Risk
$186,671 Avg. total comp.
+$431
Communications
$186,240 Avg. total comp.
Business Development
$151,090 Avg. total comp.
-$35k

Investor Relations Manager Compensation by Gender (All Companies)

The average female Investor Relations Manager at companies similar size to Roche Molecular Systems reported making $152,500, while the average male Investor Relations Manager at similar sized companies reported making $75,500.

Investor Relations Manager Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Investor Relations Manager at companies similar size to Roche Molecular Systems reported making $175,000, while the average Caucasian Investor Relations Manager at similar sized companies reported making $70,250.

How Investor Relations Managers at Roche Molecular Systems Rate Their Compensation

The majority of Investor Relations Managers at Roche Molecular Systems believe they're compensated fairly. 100% of Investor Relations Managers at Roche Molecular Systems say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at Roche Molecular Systems

×
Rate your company